Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.438.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.49 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.15.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.273NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.4.13 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.358NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.60NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.159NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.510NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.91NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.227NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.555NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.513NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.4.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XACNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.1.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XZNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1230.04Singapore
BA.4.6.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBJNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EJ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DQ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.31.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.77NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GW.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.367NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.3.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.385NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.244NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JD.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.17.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.7.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.10.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KG.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used